glp-1 news october 1 2025 Drugs: Pulse Survey (U.S.) Top GLP-1 Agonists Balance Weight

Last Published 01.01.2026 Effective Date: 01.01.2026 This policy addresses the use of Luxturna (voretigene neparvovec-rzyl) for the treatment of inherited retinal dystrophies (IRD) caused by mutations in the retinal pigment epithelium-specific protein 65kDa (RPE65) gene

The World Health Organization now classifies it as a chronic medical condition, recognizing metabolic and genetic factors that can predispose individuals to the disease

Since it is administered as an injection once weekly, it also fits more easily into busy routines

Common Reasons for Stalled Weight Loss on GLP-1 medication When starting on a weight loss journey with GLP-1 medication, its important to maintain realistic expectations for gradual and sustainable progress